Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Revenue

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹9,360 Cr₹7,845 Cr₹7,767 Cr₹895,983 Cr₹6,969 Cr

What is the latest Revenue of DIVIS LABORATORIES ?

The latest Revenue ratio of DIVIS LABORATORIES is ₹9,360 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹9,360 Cr
Mar2025₹7,845 Cr
Mar2024₹7,767 Cr
Mar2023₹895,983 Cr
Mar2022₹6,969 Cr

How is Revenue of DIVIS LABORATORIES Trending?

Years Revenue % Change
Mar2026 ₹9,360 Cr
19.31
Mar2025 ₹7,845 Cr
1.00
Mar2024 ₹7,767 Cr
-99.13
Mar2023 ₹895,983 Cr
12,755.96
Mar2022 ₹6,969 Cr -

Compare Revenue of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹244,791.0 Cr -1.7% 0.2% 39.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics
MANKIND PHARMA ₹93,967.8 Cr -5.2% 1.2% -4.2% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-1.7%

0.2%

39.5%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses